Printer Friendly

CVS, GSK join in initiative to help smokers quit.

CHICAGO -- GSK Consumer Healthcare and CVS Health have partnered with the American Lung Association's (ALA's) Lung Force initiative to help people improve their health by quitting smoking.

The ALA said that GSK Consumer Healthcare will donate $1 to Lung Force for every box of Nicorette or NicoDerm CQ purchased at CVS Pharmacy through December 2, up to $100,000.

In addition to promoting smoking cessation, the program aims to raise awareness about lung cancer during November's Lung Cancer Awareness Month.

All of the donations will go to support Lung Force's investment in lung cancer research and patient education, including lung cancer prevention, early detection, tumor testing and advocacy for more federal research funding.

CVS is the national sponsor of Lung Force.

Statistics indicate that assistance such as nicotine replacement therapy (NRT) can be effective in helping smokers quit, according to the studies cited by ALA.

Of the more than 36.5 million smokers in the United States, nearly 70% want to quit, the association reported.

However, only approximately 3% to 5% of smokers who attempt to quit cold turkey are successful. In fact, studies show that when combined with behavioral support, using NRT can double a smoker's chances of quitting successfully.

Also in recognition of Lung Cancer Awareness Month, ALA released findings from its fourth annual Lung Health Barometer, which revealed critically low awareness of the lifesaving potential of lung cancer screening.

The survey, which polled 1,400 men and women, including high-risk current and former smokers, aims to provide a better understanding of what Americans know about lung cancer and lung cancer screening.

For the general population, the survey found that only 3% of women cite lung cancer as a chief health concern, even though one woman is diagnosed with lung cancer every five minutes in the United States. Eighty-seven percent of the population isn't familiar with the low-dose CT scan, which the association noted is the only approved lung cancer screening for early detection.

At the same time, 62% believe that not enough is being done to heighten awareness of lung cancer.

ALA recently partnered with the Ad Council to launch "Saved By The Scan," the first national public service advertising campaign to educate Americans on the benefits of early detection of lung cancer. The low-dose CT scan reduces the risk of death from lung cancer by detecting lung cancer in the early stages, before symptoms arise, when the disease is more curable.

Caption: GSK is donating $1 for each of its NRT products sold at CVS.

COPYRIGHT 2017 Racher Press, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Chain Drug Review
Date:Nov 20, 2017
Words:419
Previous Article:NACDS tabs SNL star for its foundation dinner.
Next Article:Peters appointed sales EVP at Diplomat.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters